Top Industry Leaders in the Cancer Immunotherapy Market
Latest Americas Cancer Immunotherapy Companies Updates:
Merck & Co.'s Keytruda (pembrolizumab) Wins FDA Approval for First-Line Metastatic Esophageal Cancer: This January 2024 development expands treatment options for this aggressive cancer, potentially offering hope for patients in North and South America.
Roche and Foundation Medicine Team Up for Latin American Precision Immunotherapy: This October 2023 collaboration aims to make advanced genetic testing more accessible, paving the way for personalized immunotherapy strategies in Latin America.
Inovio's INO-5401 Shows Positive Phase 2 Trial Results for Glioblastoma: This December 2023 breakthrough with a novel DNA vaccine could lead to new treatment options for this challenging brain cancer, impacting patients across the Americas.
List of Americas Cancer Immunotherapy Key companies in the market:
- Amgen Inc. (U.S.)
- AstraZeneca (U.K)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bayer AG (Germany)
- Bristol-Myers Squibb Company (U.S.)
- Eli Lilly and Company (U.S.)
- Merck & Co., Inc. (U.S.)
- Pfizer Inc. (U.S.)
- Novartis AG (Switzerland)